The role of PAR1 across different cancers, where it acts variably as an oncogene in breast and prostate cancers and is involved in malignancy processes like angiogenesis, tumor invasiveness, and metastasis, is well documented [[54], [55], [56]]. This evidence concerns the gene F2R and prostate cancer.